Childen's Hospital Boston
International Visitorsdotted lineRequest Appointmentdotted lineDirections
 advanced search
About Us Find a Specialist Locations Careers Press Room Giving To
Clinical Services For Patients & Families For Health Professionals Research
or find by letter:  A-F  G-L  M-R  S-Z

Hematology/Oncology Home Page

 Hematology/Oncology
  History
  Program Direction
  Faculty
  Fellows
 Clinical Training
  Research Training
  Boston and New England
  Training Record
  Applying
 Email this page
 X
Flower Clinical Training: Clinical Statistics
Back to main Clinical Training page
Hematology
 
New patients/year
Total active patients
Red cell disorders    
Sickle cell disease
20
220
Hereditary spherocytosis
10
100
Thalassemia major/intermedia
10
60
Other hereditary disorders
22
45
Anemia workups/consultations
350
150
White cell disorders    
Leukopenia, neutropenia, leukocytosis
120
60
Hereditary WBC function disorders
3
15
Coagulopathies    
von Willebrand disease
50
>200
Hemophilia
8
130
Other coagulation defects
5
30
Thrombotic disorders, hypercoagulation
100
150
Coagulation consults
400
---
Platelet disorders    
ITP
55
150
Other
10
50
Bone marrow failure syndromes
10
50
Ambulatory -2500 hematology patient visits per year, approximately 600 chronic transfusion visits/year (thalasemia ajoe, sickle cell disease, bone marrow failure, rare anemias). Inpatient 5+/-3 patients on the hematology inpatient service daily, 5+/-4 consults daily on hematology service, plus 1-4 consults daily on anticoagulation service.
Oncology
  New patients/year Total active patients
Histiocytosis
1
20
Leukemia    
ALL
61
93
AML
10
26
Lymphoma    
Hodgkin's disease
17
23
Non-Hodgkin's lymphoma
22
26
Sarcomas
53
51
Wilm's tumor
9
12
Neuroblastoma
24
50
Brain tumors
80
90
Other tumors
57
81
Ambulatory (Jimmy Fund Clinic)- 11,500 oncology and stem cell transplantation patient visits/year.

Inpatient (6 North)- average of 16 oncology patients per day on 21-bed hematology/oncology ward plus 8-10 off-service oncology patients and oncology consults.

In addition to the patients diagnosed and treated at Children's Hospital Boston and Dana-Farber Cancer Institute, we see many patients referred from other centers with difficult oncologic problems.

Stem Cell Transplantation
 
Transplants/year
 
Type of transplant 2006 2007
Autologous
23
12
Allogeneic
47
53
Donor source    
Bone marrow
38
46
Cord blood
8
5
Peripheral blood stem cells
24
14
Conditions treated    
Leukemia
34
36
Lymphoma
7
5
Hematologic disorders
10
9
Neuroblastoma, solid turmors, brain tumors
13
12
Metabolic diseases, Immunodeficiency
6
3
     
Inpatient (6 West)- average of 10-12 transplant patients per day on a newly renovated 13-bed stem cell transplant unit. New patient evaluations and follow-ups take place at Dana-Farber's Jimmy Fund Clinic. The stem cell transplantation group consists of 13 attending physicians, 1 physician's assistant, two nurse practioners, and a two transplant coordinators.
Cooperative Group, Centers and Funded Research Networks
Cooperative Cancer Group Children's Oncology Group (COG) New Approaches in Neuroblastoma Therapy Phase I Program for Children's Oncology Group  
Nationally Funded Centers    
  Sickle cell disease Boston Sickle Center
    New England Pediatric Sickle Cell Consortium
  Hemophilia Boston Hemophilia Center
  Cancer Dana-Farber/Harvard Cancer Center
  Genetics Boston Center for Genetic Blood Diseases
Funded Research Networks    
  Pediatric Research Glaser Clinical Research Network
  Thalassemia Thalassemia Clinical Research Network
 X
Contact Us Site Map Privacy Accessibility Give Now en Español